There remains a substantial gap throughout Europe between the need and desire for HIV pre-exposure prophylaxis (PrEP) and the number of people actually using it, an online workshop convened towards the end of last year by the European AIDS Clinical Society (EACS) heard. The workshop on PrEP was the second part of its fourth Standard… Read More »
To eliminate hepatitis C in people with HIV in Scotland, healthcare providers will need to reach people not on HIV treatment and step up testing for hepatitis C in people who inject drugs, an analysis of Scottish surveillance data published in HIV Medicine shows. Scotland has a high prevalence of hepatitis C among people with… Read More »
The risk of dementia in older age is increased by 58% for people living with HIV compared to their HIV-negative peers, according to US research published in the online edition of AIDS. The average age at dementia diagnosis was much younger for people with HIV: 67 years compared to 78 years for people without HIV.… Read More »
A US study has concluded that weight gain is greater by around 2 to 4 kg in HIV-positive people taking bictegravir or dolutegravir as part of their first antiretroviral therapy (ART), compared to their counterparts using other drug regimens. A similar effect was reported in those using the protease inhibitor darunavir. The study led by… Read More »